Sorry, this entry is only available in Ukrainian and Russian.
Вас может заинтересовать:
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
WEB only
Pharmaceutical company 'Darnytsia' with the support of consulting company BPI Group conducted training for manufacturing enterprises. During the training, held at its own production facilities, Darnytsia’s specialists talked about the…